1. PATIENT‐REPORTED OUTCOMES (PROs) IN WALDENSTRÖM MACROGLOBULINEMIA (WM) PATIENTS TREATED WITH IBRUTINIB‐RITUXIMAB IN THE INNOVATE STUDY. (12th June 2019) Authors: Tedeschi, A.; Dimopoulos, M.A.; Trotman, J.; García‐Sanz, R.; Macdonald, D.; Mahe, B.; Herbaux, C.; Heffner, L.T.; Tam, C.S.; Varettoni, M.; Palomba, M.L.; Matous, J.V.; Shustik, C.; Kastritis, E.; Treon, S.P.; Li, J.; Poulsen, E.G.; Hauns, B.; Buske, C.; Leblond, V. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 235 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗